LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL

被引：0

作者：

Ruperto, N. ^{[1
]}

Brunner, H. I. ^{[2
]}

Quartier, P. ^{[3
]}

Constantin, T. ^{[1
]}

Alexeeva, E. ^{[1
]}

Schneider, R. ^{[2
]}

Kone-Paut, I. ^{[1
]}

Schikler, K. ^{[2
]}

Marzan, K. ^{[2
]}

Wulffraat, N. ^{[1
]}

Padeh, S. ^{[1
]}

Chasnyk, V. ^{[1
]}

Wouters, C. ^{[1
]}

Kuemmerle-Deschner, J. B. ^{[1
]}

Kallinich, T. ^{[1
]}

Lauwerys, B. ^{[4
,5
]}

Haddad, E. ^{[2
]}

Nasonov, E. ^{[1
]}

Trachana, M. ^{[1
]}

Vougiouka, O. ^{[1
]}

Leon, K. ^{[6
]}

Speziale, A. ^{[7
]}

Lheritier, K. ^{[7
]}

Martini, A. ^{[1
]}

Lovell, D. ^{[2
]}

机构：

[1] PRINTO Ist Gaslini, Genoa, Italy

[2] PRCSG, Cincinnati, OH USA

[3] Necker Enfants Malad Hosp, Paris, France

[4] Clin Univ St Luc, Brussels, Belgium

[5] Catholic Univ Louvain, Brussels, Belgium

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Novartis Pharma AG, Basel, Switzerland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1136/annrheumdis-2016-eular.3835

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0215

引用

页码：265 / 266

页数：2

共 50 条

[1] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From an Open-Label, Long-Term Follow-up Study
Brunner, Hermine
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Schneider, Rayfel
Kone-Paut, Isabelle
Schikler, Kenneth N.
Marzan, Katherine
Wulffraat, Nico
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Vritzali, Eleni
Martini, Alberto
Lovell, Daniel
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 7 - 8
[2] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
Brunner, Hermine L.
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Schneider, Rayfel
Kone-Paut, Isabelle
Schikler, Kenneth
Marzan, Katherine
Wulffraat, Nico
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Vritzali, Eleni
Lovell, Daniel J.
Martini, Alberto
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[3] Efficacy and Safety Of Long-Term Rituximab Use In Patients With Systemic Juvenile Idiopathic Arthritis: The Results Of 5-Year Follow-Up In Real Clinical Practice
Alexeeva, Ekaterina
Baranov, Alexander
Valieva, Saniya
Bzarova, Tatyana
Denisova, Rina
Isayeva, Kseniya
Sleptsova, Tatyana
Mitenko, Elena
Chistyakova, Evgeniya
Fetisova, Anna
Semikina, Elena
Akulova, Svetlana
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S925 - S925
[4] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
Brunner, Hermine
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Kone-Paut, Isabelle
Marzan, Katherine
Wulffraat, Nico
Schneider, Rayfel
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Vritzali, Eleni
Lheritier, Karine
Martini, Alberto
Lovell, Daniel
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
[5] Long-term safety and efficacy of rotigotine in patients with idiopathic RLS: 5-year results front a prospective multinational open-label follow-up study
Hogl, I.
Trenkwalder, C.
Garcia-Borreguero, D.
Kohnen, R.
Poewe, W.
Stiasny-Kolster, K.
Bauer, L.
Fichtner, A.
Schollmayer, E.
Oertel, W.
[J]. MOVEMENT DISORDERS, 2010, 25 (07) : S517 - S517
[6] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
Iwata, Naomi
Nishimura, Kenichi
Hara, Ryoki
Imagawa, Tomoyuki
Shimizu, Masaki
Tomiita, Minako
Umebayashi, Hiroaki
Takei, Syuji
Seko, Noriko
Wakabayashi, Ryota
Yokota, Shumpei
[J]. MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
[7] Long-Term Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
Alexeeva, Ekaterina
Denisova, Rina
Dvoryakovskaya, Tatyana
Isaeva, Ksenia
Kriulin, Ivan
Alshevskaya, Alina
Moskalev, Andrey
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[8] Long-Term Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a PHASE III Extension Study
Brunner, Hermine I.
Ruperto, Nicolino
Quartier, Pierre
Constantin', Tamas
Alexeeva, Ekaterina
Kone-Paut, Isabelle
Marzan, Katherine
Wulffraat, Nico
Schneider, Rayfel
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Vritzali, Eleni
Lheritier, Karine
Martinis, Alberto
Lovell, Daniel J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[9] Long-term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open-label, follow-up trial
Lagae, Lieven
Klotz, Kerstin Alexandra
Fogarasi, Andras
Floricel, Florin
Reichel, Christoph
Elshoff, Jan-Peer
Fleyshman, Sofia
Kang, Harriet
[J]. EPILEPSIA, 2023, 64 (11) : 2934 - 2946
[10] Long-term follow-up of patients with systemic onset of juvenile idiopathic arthritis and amyloidosis
Musiej-Nowakowska, E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 448 - 448

← 1 2 3 4 5 →